BioSpace News Archive

Business

Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial Results

Cellect Biotech today provided a corporate update and announced financial results for the third quarter ended September 30, 2017.

November 22, 2017

·

26 min read

Drug Development

Immunomic Therapeutics: Dr. Duane Mitchell Reports Findings of Study Aimed at Aggressive Brain Cancer

The study’s results demonstrated an enhanced T cell expansion, activation, and antigen-specific killing of GBM tumor cells with use of the full-length LAMP-1 pp65 chimeric RNA pulsed DCs.

November 22, 2017

·

4 min read

BioMidwest

Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA

konopedia and Konica Minolta will demonstrate the integrated breast reporting package at the Konica Minolta booth (South Hall #1919) and Ikonopedia will also be available for educational meetings in MS224, located in the South Exhibit Hall.

November 22, 2017

·

4 min read

Ampio Announces Publication of Ampion Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal

The article describes the efficacy and safety of Ampion (LMWF-5A) in an integrated analysis of three single injection randomized controlled studies of severe osteoarthritis of the knee.

November 22, 2017

·

4 min read

Business

SCRS Welcomes New Global Impact Partner, CPi Global CRO

SCRS’ GIP Program provides a unique opportunity for sponsors, CROs and vendors to engage with SCRS and its members in an impactful manner.

November 22, 2017

·

1 min read

Business

Jacobson Pharma Announces FY2018 Interim Results

During the Reporting Period, the Group’s revenue increased by 29.1% to HK$743.0M.

November 22, 2017

·

5 min read

FDA

Teligent Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%

This is Teligent’s ninth approval for 2017.

November 22, 2017

·

2 min read

Drug Development

DiaMedica Therapeutics Announces Ethics Committee Clearance at First Site to Initiate REMEDY Phase II Trial for Acute Ischemic Stroke

REMEDY is a multi-center, double-blind, randomized, placebo-controlled Phase 2 clinical trial investigating DM199 treatment in patients who have suffered a moderate to moderately severe acute ischemic stroke.

November 22, 2017

·

5 min read

Pluristem Granted Key U.S. Patent for Skeletal Muscle Regeneration - a Meaningful Asset Ahead of Upcoming Phase III Femoral Neck Fracture Study

This key patent, which has already been granted in Europe, Hong Kong and Israel, addresses the use of MSCs for skeletal muscle regeneration used either directly after, or shortly after, post-surgical muscle injury.

November 22, 2017

·

5 min read

Business

Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors

Mr. Dan is a Canadian businessman, philanthropist and Tony-Award winning theatre producer (MEMPHIS).

November 22, 2017

·

7 min read